Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
- Institution
- BRIGHAM AND WOMEN'S HOSPITAL, MA
- Principal investigator
- Peter The Sage
- Funding
- $494K
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
Pathogenic antibodies promote and exacerbate allergic inflammation. Antibody responses are controlled by a delicate balance between stimulatory signals from T follicular helper (Tfh) cells and inhibitory signals from T follicular regulatory (Tfr) cells. Alterations in this balance can lead to pathogenic antibody responses and disease. Although subsets of Tfh and Tfr cells have been implicated in controlling allergies, the precise mechanisms of how these cells regulate distinct stages of allergic inflammation are not currently known. We hypothesize that individual subsets of Tfh and Tfr cells have unique and multifaceted roles during distinct stages of allergic inflammation. Moreover, we hypothesize that the composition of Tfh and Tfr subsets evolves over time to orchestrate allergic disease. By elucidating how Tfh and Tfr cell subsets control allergic inflammation, new strategies can be developed that specifically target pathogenic responses during allergies without affecting broad immune responses. To test these hypotheses, we have developed a number of novel mouse models for the in-depth study of the roles of specialized subsets of Tfh and Tfr cells in allergies. Our aims are to 1) Determine how Tfr cells control allergic inflammation through regulating B, Tfh13 and Tfh21 cells; and 2) Assess how the evolving composition of unique Tfh cell subsets orchestrates allergic inflammation. Our goals are to elucidate mechanisms used by Tfh and Tfr cell subsets to regulate allergies, and to identify targeted strategies to limit allergic inflammation.
LOADING MOONBASE SCORE
Questions for BRIGHAM AND WOMEN'S HOSPITAL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Brigham and Women'S HospitalNot yet scored
Antibody Mediated Rejection and Post-transplantation Anti-Viral Immunity in Aging
Peter The Sage · $695K · 2024–2029
- NIH · Brigham and Women'S HospitalNot yet scored
Control of Humoral and Cellular Immunity to Viral Infections of the Lung by Follicular CD8 T Cells
Peter The Sage · $490K · 2021–2026
- NIH · Brigham and Women'S Hospital64
Making the invisible visible: An automated clinical decision support tool for Intimate Partner Violence Risk and Severity Prediction (AIRS)
Bharti Khurana · $796K · 2022–2027